AbbVie received final approval from the European Commission for its acquisition of Allergan.
GI & Endoscopy
Citing market conditions, Bausch Health made a series of moves to keep its debt at current levels.
A Utah gastroenterologist has agreed to pay the HHS' Office of Civil Rights $100,000 for a corrective action plan related to a potential violation of a HIPAA security rule.
The New York State Board for Professional Medical Conduct revoked the license of Mirza Beg, MD, who sent sexually explicit text messages to a minor who was his former patient, Syracuse.com reports.
Four must-read articles for gastroenterologists:
Takeda Pharmaceuticals continues to combat its Shire acquisition-related debt by selling off another set of non-core assets to Hypera in Brazil, the company announced March 2.
Children's Hospital of Philadelphia researchers have developed a 3D-imaging method that allows them to view the enteric nervous system, News-Medical.net reports.
The FDA awarded Pavmed's EsoGuard Esophageal DNA Test breakthrough device designation to aid in diagnosing Barrett's esophagus.
Orlando, Fla.-based Digestive and Liver Center of Florida implemented AndorHealth's ThinkAndor, an internal communication and collaboration tool that interprets EHR systems and presents information in a more-easily interpretable format.
Here are five recent updates on Exact Sciences and its product, Cologuard:
